| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2017 | Anti-Parkinsonian effects of β-amyrin are regulated via LGG-1 involved autophagy pathway in Caenorhabditis elegans | Wei C.-C.; Chang C.-H.; Liao V.H.-C.; VIVIAN LIAO | Phytomedicine | 13 | 28 | |
| 2016 | Antioxidative activities of both oleic acid and Camellia tenuifolia seed oil are regulated by the transcription factor DAF-16/FOXO in Caenorhabditis elegans | Wei C.-C.; Yen P.-L.; Chang S.-T.; Cheng P.-L.; Lo Y.-C.; Liao V.H.-C.; SHANG-TZEN CHANG | PLoS ONE | 16 | 23 | |
| 2016 | Antioxidative activities of both oleic acid and Camellia tenuifolia seed oil are regulated by the transcription factor DAF-16/FOXO in Caenorhabditis elegans | Wei C.-C.; Yen P.-L.; Chang S.-T.; Cheng P.-L.; Lo Y.-C. ; Liao V.H.-C. | PLoS ONE | 18 | 23 |  |
| 2020 | Association of heart rate trajectories with the risk of adverse outcomes in a community-based cohort in Taiwan | Wei C.-C.; Chen P.-C.; Hsu H.-C.; Su T.-C.; HUNG-JU LIN ; Chen M.-F.; Lee Y.-T.; Chien K.-L. | PeerJ | | 1 | |
| 2020 | Association of heart rate trajectories with the risk of adverse outcomes in a community-based cohort in Taiwan | Wei C.-C.; Chen P.-C.; Hsu H.-C.; TA-CHEN SU ; Lin H.-J.; Chen M.-F.; Lee Y.-T.; Chien K.-L. | PeerJ | | 1 | |
| 2020 | Association of heart rate trajectories with the risk of adverse outcomes in a community-based cohort in Taiwan | Wei C.-C.; Chen P.-C.; Hsu H.-C.; Su T.-C.; Lin H.-J.; Chen M.-F.; Lee Y.-T.; KUO-LIONG CHIEN | PeerJ | | 1 | |
| 2020 | Association of heart rate trajectory patterns with the risk of adverse outcomes for acute heart failure in a heart failure cohort in Taiwan | Wei C.-C.; Shyu K.-G.; KUO-LIONG CHIEN | Acta Cardiologica Sinica | | 1 | |
| 2010 | Better short-term clinical response to etanercept in Chinese than Caucasian patients with active ankylosing spondylitis | Chou C.-T.; Tsai C.-Y.; Liang T.-H.; Chang T.-M.; Lai C.-H.; Wei C.-C.; Chen K.-H.; Lin S.-C.; CHIA-LI YU ; Liou L.-B.; Luo S.-F.; Lee C.-S.; Hsue Y.-T.; Huang C.-M.; Chen J.-H.; Lai N.-S.; Cheng H.-H.; Cheng T.-T.; Lai H.-M.; Tsai W.-C.; Yen J.-H.; Lu L.-Y.; Chang C.-P. | Modern Rheumatology | 10 | 8 | |
| 2012 | Bortezomib enhances radiation-induced apoptosis in solid tumors by inhibiting CIP2A | Huang C.-Y.; Wei C.-C.; Chen K.-C.; Chen H.-J.; ANN-LII CHENG ; Chen K.-F. | Cancer letters | | 25 | |
| 2012 | Bortezomib enhances radiation-induced apoptosis in solid tumors by inhibiting CIP2A | CHAO YUAN HUANG ; Wei C.-C.; Chen K.-C.; Chen H.-J.; Cheng A.-L.; Chen K.-F. | Cancer Letters | | 25 | |
| 2009 | Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors | Kuo L.-T.; Kuo K.-T.; Lee M.-J.; Wei C.-C.; Scaravilli F.; Tsai J.-C.; Tseng H.-M.; Kuo M.-F.; YONG-KWANG TU | International Journal of Cancer | 32 | 25 | |
| 2009 | Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors | LU-TING KUO ; Kuo K.-T.; Lee M.-J.; Wei C.-C.; Scaravilli F.; Tsai J.-C.; Tseng H.-M.; Kuo M.-F.; Tu Y.-K. | International Journal of Cancer | 32 | 25 | |
| 2009 | Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors | Kuo L.-T.; Kuo K.-T.; Lee M.-J.; Wei C.-C.; Scaravilli F.; Tsai J.-C.; Tseng H.-M.; MENG-FAI KUO ; Tu Y.-K. | International Journal of Cancer | 32 | 25 | |
| 2009 | Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors | Kuo L.-T.; KUAN-TING KUO ; Lee M.-J.; Wei C.-C.; Scaravilli F.; Tsai J.-C.; Tseng H.-M.; Kuo M.-F.; Tu Y.-K. | International Journal of Cancer | 31 | 25 | |
| 2009 | Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors | Kuo L.-T.; Kuo K.-T.; Lee M.-J.; Wei C.-C.; Scaravilli F.; JUI-CHANG TSAI ; Tseng H.-M.; Kuo M.-F.; Tu Y.-K. | International Journal of Cancer | 31 | 25 | |
| 2009 | Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors (International Journal Cancer (2009) 124, (2872-2879)) | Kuo L.-T.; Kuo K.-T.; Lee M.-J.; Wei C.-C.; Scaravilli F.; Tsai J.-C.; Tseng H.-M.; MENG-FAI KUO ; Tu Y.-K. | International Journal of Cancer | 0 | 0 | |
| 2009 | Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors (International Journal Cancer (2009) 124, (2872-2879)) | Kuo L.-T.; Kuo K.-T.; Lee M.-J.; Wei C.-C.; Scaravilli F.; JUI-CHANG TSAI ; Tseng H.-M.; Kuo M.-F.; Tu Y.-K. | International Journal of Cancer | 0 | 0 | |
| 2009 | Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors (International Journal Cancer (2009) 124, (2872-2879)) | Kuo L.-T.; KUAN-TING KUO ; Lee M.-J.; Wei C.-C.; Scaravilli F.; Tsai J.-C.; Tseng H.-M.; Kuo M.-F.; Tu Y.-K. | International Journal of Cancer | 0 | 0 | |
| 2009 | Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors (International Journal Cancer (2009) 124, (2872-2879)) | Kuo L.-T.; Kuo K.-T.; Lee M.-J.; Wei C.-C.; Scaravilli F.; Tsai J.-C.; Tseng H.-M.; Kuo M.-F.; YONG-KWANG TU | International Journal of Cancer | 0 | 0 | |
| 2017 | Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial | Nash P.; Kirkham B.; Okada M.; Rahman P.; Combe B.; Burmester G.-R.; Adams D.H.; Kerr L.; Lee C.; Shuler C.L.; Genovese M.; Ahmed K.; Alper J.; Barkham N.; Bennett R.E.; Garc?a F.J.B.; Alonso R.B.; Blumstein H.B.; Brooks M.S.; Burmester G.-R.; Cagnoli P.; Caldron P.H.; Cantagrel A.; Chen D.-Y.; Churchill M.A.; Jr, Codding C.E.; Combe B.; Deane P.M.G.; Del Giudice J.; Deodhar A.A.; Dhar R.K.; Dokoupilova E.; Egan R.M.; Everding A.; Gal?ndez E.; Genovese M.; Goddard D.H.; Gottlieb A.; Goupille P.; Griffin R.M.; Gupta R.C.; Hall S.; Hatti K.; Howell M.P.; Huang Y.-H.; Jajoo R.; Janssen N.M.; Kiltz U.; Kivitz A.J.; Klein S.J.; Korkosz M.P.; Kotha R.; Kremer J.M.; Lue C.; de la Fuente J.L.M.; Marzo-Ortega H.; Masmitja J.G.; Mease P.J.; Meroni P.L.; Mueller E.C.; Nandagudi A.C.; Nash P.; Fern?ndez-Nebro A.; Neuwelt C.M.; Orbai A.M.; Oza M.R.; Parks D.L.; Pattanaik D.; Rell-Bakalarska M.E.; Rosmarin D.; Roussou E.; Rychlewska-Hanczewksa A.I.; Sikes D.H.; Stack M.T.; Sunkureddi P.; Tahir H.; Tha?i D.; TSEN-FANG TSAI ; Turkiewicz A.M.; Unger L.; Cabello R.V.; Wagner U.; Wei C.-C.; Wells A.F.; Youssef P.; Zielinska A. | The Lancet | 243 | 242 | |
